🧬 SinoBioData Academic Portal
Open AccessDOI: 10.12307/2026.21204Original Research

Extracellular matrix stiffness affects the proliferation activity of bone marrow stromal stem cells

GAO Feng¹,WANG Jiliang¹,WANG Hongbo¹,YANG Yongsheng¹,LIU Yuan¹,FU Su¹

Inner Mongolia Hospital of Traditional Chinese Medicine, Hohhot 010000, Inner Mongolia Autonomous Region, China

Read Executive PreviewQuick FAQ
Extracellular matrix stiffness affects the proliferation activity of bone marrow stromal stem cells
Graphical Abstract / Figure
Published In
Chinese Journal of Tissue Engineering Research
Published:January 15, 2026Edition:Vol 1895, Issue 23 • pp. 100-112Citation:GAO Feng et al. (2026), Chinese Journal of Tissue Engineering Research
Impact FactorPremier Chinese Biomedical Journal indexed in SinoBioData: Chinese Journal of Tissue Engineering Research (中国组织工程研究).
Sponsored Research Partner

Key Takeaways & Executive Findings

  • • Extracellular matrix stiffness modulates bone marrow stromal stem cell proliferation via a novel YAP/primary cilia mechanism. • Rigid substrates enhance proliferation and activate Wnt/β-catenin signaling, while inducing primary cilia shortening and YAP nuclear accumulation. • YAP knockdown abolishes stiffness-dependent differences in proliferation and cilia length, confirming its central role. • These findings provide insights for designing tissue engineering scaffolds with optimal mechanical properties.
Sponsored Research Highlight

Abstract

BACKGROUND: In tissue engineering bone construction, the physical properties of the scaffold can directly affect the activity and repair effect of seed cells, among which extracellular matrix hardness is a key factor affecting seed cell proliferation activity. Primary cilia and YAP proteins have been shown to be classical mechanoreceptors and downstream transduction factors, which may directly mediate this mechanism. OBJECTIVE: To investigate the regulatory effect of extracellular matrix hardness on the proliferation activity of bone marrow stromal stem cells and the related mechanisms. METHODS: Bone marrow stromal stem cells were passaged and seeded under different hardness of polydimethylsiloxane extracellular matrix conditions (soft, median, and rigid) for culture. Cell proliferation activity was detected using CCK-8 assay. Transcriptional activity of proliferation genes c-myc and CCND1 was measured using qRT-PCR. Activation of Wnt/β-catenin pathway was evaluated using western blot assay. Primary cilia and YAP protein expression levels were evaluated by acetylated α-tubulin and YAP immunofluorescence staining. After passage, bone marrow stromal stem cells were inoculated on polydimethylsiloxane-based membranes of different hardness (soft and hard) for culture. Then siRNA was used to interfere with YAP protein expression. Western blot assay was used to detect YAP, phosphorylated GSK-3β, and β-catenin protein expression. qRT-PCR was used to detect the transcriptional activity of c-myc and CCND1. The length of primary cilia was analyzed after immunofluorescence staining of acetylated α-tubulin. RESULTS AND CONCLUSION: The cell proliferation activity, c-myc and CCND1 transcriptional activity under rigid polydimethylsiloxane conditions were significantly higher than those under soft and median hardness, and the activation of Wnt/β-catenin pathway was stronger. Immunofluorescence staining showed that rigid polydimethylsiloxane induced shortening of primary cilia and increased YAP-positive cells. After siRNA interference of YAP expression, the differences in YAP, phosphorylated GSK-3β, β-catenin protein expression, and c-myc and CCND1 transcriptional activity between groups disappeared, accompanied by the disappearance of primary cilia length differences. The results indicate that extracellular matrix stiffness regulates the proliferation activity of bone marrow stromal stem cells through a novel YAP protein/primary cilia mechanism.

1. Introduction

In tissue engineering bone construction, scaffolds loaded with cells serve as extracellular matrix components, influencing seed cell activity and repair outcomes. Recently, various novel scaffolds have been widely applied in bone tissue engineering repair [1-2], showing high potential value. Among these, scaffold stiffness can directly affect multiple activities of seed cells, including proliferation, migration, and differentiation [3-4], thereby precisely controlling cell behavior, representing an important research direction for enhancing bone repair capacity. Although numerous studies have addressed the regulation of cell activity by physical properties of the extracellular matrix, research on how matrix stiffness affects proliferation and differentiation of bone marrow stromal stem cells remains insufficient [5]. This study aims to reveal the underlying molecular mechanisms in this process.

Recent literature has confirmed that primary cilia and YAP protein/Hippo pathway can transduce mechanical signals/extracellular matrix stiffness signals, activating downstream pathways and affecting cell activity [6-7]. These two have interactive mechanisms: primary cilia can mediate YAP activity to influence inflammatory responses [8-9], and extracellular matrix stiffness can directly affect Wnt1 and β-catenin protein expression, regulating cell proliferation [3]. This study proposes that scaffold/extracellular matrix stiffness may regulate seed cell proliferation through a primary cilia/YAP signaling mechanism, activating the downstream Wnt/β-catenin pathway. These results will help elucidate the 'scaffold stiffness-cell activity' regulatory mechanism and provide new insights for tissue engineering bone construction and mechanical microenvironment design.

SinoBioData Interactive Document Reader
Page 1–5 of Preview
100%
Download Full PDF

Loading authentic research manuscript (Pages 1–5)...

Sponsored Research Partner
Cite This Research Paper
GAO Feng, WANG Jiliang, WANG Hongbo, YANG Yongsheng, LIU Yuan, FU Su (2026). Extracellular matrix stiffness affects the proliferation activity of bone marrow stromal stem cells. Chinese Journal of Tissue Engineering Research. https://doi.org/10.12307/2026.21204
SinoBioData Academic & Legal Disclaimer

Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.

Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.

Frequently Asked Questions

How does extracellular matrix stiffness affect bone marrow stromal stem cell proliferation?

Extracellular matrix stiffness modulates proliferation through a novel mechanism involving YAP protein and primary cilia. Rigid substrates enhance proliferation, activate Wnt/β-catenin signaling, and induce primary cilia shortening and YAP nuclear accumulation.

What is the role of YAP protein in this process?

YAP protein acts as a key mechanotransducer. Its knockdown abolishes stiffness-dependent differences in proliferation and cilia length, indicating its central role in mediating the effects of matrix stiffness.

What is the significance of primary cilia in this context?

Primary cilia are mechanosensory organelles that respond to matrix stiffness. Their length changes with stiffness, and they interact with YAP to regulate downstream signaling pathways such as Wnt/β-catenin.

What are the implications for tissue engineering?

These findings suggest that optimizing scaffold stiffness can enhance seed cell proliferation, providing a basis for designing mechanical microenvironments that improve bone repair outcomes.

What experimental methods were used in this study?

The study used CCK-8 assay for proliferation, qRT-PCR for gene expression, western blot for protein levels, and immunofluorescence staining for primary cilia and YAP localization. siRNA was used to knock down YAP.

Recommended Scientific Literature & Research Partners

Related Technical Papers & Translations

Research Paper
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.

Read Abstract & PDF
Research Paper
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.

Read Abstract & PDF
Research Paper
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.

Read Abstract & PDF